Pasireotide in an insulin-requiring diabetic acromegalic patient without worsening of hyperglycemia
Long-acting pasireotide is an effective treatment option for acromegaly, but it is associated with hyperglycemia, which could impact its use in patients with diabetes. We present a case of a 53-year-old man with acromegaly and type 2 diabetes mellitus (glycated hemoglobin (HbA1c): 7.5%), who refused...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Bioscientifica
2017-05-01
|
| Schriftenreihe: | Endocrinology, Diabetes & Metabolism Case Reports |
| Online-Zugang: | https://www.edmcasereports.com/articles/endocrinology-diabetes-and-metabolism-case-reports/10.1530/EDM-17-0003 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|